HIMS Stock — Hims & Hers Health Inc.

Hims & Hers Health Inc. (HIMS)

HIMS is a low-cost Stock. Fund total return is 194.3% over the past 7 years, 11.3 points ahead of SPY at 183.0%.

Hims & Hers Health operates a consumer-focused telehealth platform that connects patients with licensed healthcare professionals across the United States and multiple international markets, offering prescription medications, over-the-counter products, cosmetics, supplements, and laboratory testing services through its website and mobile app. The company focuses on areas including sexual health, hair care, skincare, weight loss, mental health, and chronic condition management. As an operating company, Hims & Hers does not currently have a stated distribution rate or regular dividend payments.

HIMS performance versus SPY

Data as of August 28, 2026.

Fund total return is 194.3% over the past 7 years, 11.3 points ahead of SPY at 183.0%. Its deepest 1-year drawdown was 76.9%.

HIMS key facts

Data as of August 28, 2026.

Asset type

Stock

Asset class

Equity

Inception date

09/13/2019

Distribution frequency

None

Last close

$28.84

Market cap

$6,959,738,880

Average volume

14658817.0

Beta

2.415

Payout ratio

0.0

P/E ratio

57.1373

Forward P/E

58.8235

EPS

$-0.60

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) is the latest regular payout annualized by the fund's stated frequency, divided by the last close. Issuers often publish this as “Distribution Rate” on the fact sheet. Trailing-12-month yield is the sum of distributions paid in the last 12 months, split-adjusted, divided by the last close. It lags a recent raise or cut. We show a 30-day SEC yield when the fund publishes one. Schwab and other issuers may report a TTM distribution yield or SEC yield on a different date — all can be valid; they are not interchangeable. Fund total return uses split-adjusted close with distributions reinvested from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is what the fund did, not your personal gain/loss. Figures below use Dividend Vision data as of August 28, 2026.

Distribution rate methodology · Distribution Safety Score methodology · SEC yield

Sources and review

Data as of August 28, 2026.

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

HIMS risks and drawbacks

The deepest 1-year drawdown on record here is 76.9%.

Who may consider HIMS — and who may not

HIMS may suit someone looking for low-cost broad dividend exposure. It is a weaker fit for investors who need monthly cash flow (HIMS does not currently distribute); investors hunting double-digit covered-call yields. This is educational context, not a recommendation to buy or sell.

Compare HIMS

HIMS vs similar funds:

• HIMS vs HMYY

Frequently asked questions